The Royal Marsden is one of the world’s leading specialist cancer centres and the largest comprehensive cancer centre in Europe. Together with our academic partner, The Institute of Cancer Research, we are designated as the UK’s only National Institute for Health and Care Research Biomedical Research Centre dedicated solely to cancer and are recognised among the top four comprehensive cancer centres globally for the impact of our research on patient care. Rated Outstanding by the Care Quality Commission, the Trust is honoured to count Their Royal Highnesses The Prince and Princess of Wales as our Joint Patrons.
The Trust is entering a defining period in its development. Patient referrals have risen by approximately 30 per cent over the past five years, our partnership with the ICR continues to deepen, and significant investment is underway across our estate, our digital infrastructure and our clinical model. The opening of the Oak Cancer Centre at Sutton, the rollout of Connect, our Epic-based Digital Health Record, and well-advanced plans to expand and modernise our Chelsea site are creating the platform for the next chapter of growth and innovation. As the founder and host of RM Partners West London Cancer Alliance, the Trust also carries a national leadership responsibility for the cancer agenda that extends well beyond its own walls.
At the heart of all of this are our 5,500 colleagues, an extraordinary community of clinicians, scientists, researchers, operational and corporate professionals whose expertise and values translate scientific discovery into improved outcomes for patients in the UK and worldwide. Their dedication is reflected in our consistently outstanding patient experience scores, with 99 per cent of inpatients rating their care positively, and in the international reputation the Trust enjoys as an employer of choice in the cancer field. Building on this, we are committed to fostering an inclusive, supportive and modern working environment in which every colleague feels valued, heard and able to do their best work.
The next Chief People Officer will build on strong foundations and lead the next phase of the people agenda for the Trust. Reporting to the Chief Executive, Dame Cally Palmer CBE, and as a full member of the Executive Team and Trust Board, the CPO will lead the development and delivery of workforce strategy across The Royal Marsden. The role carries responsibility for workforce planning, organisational development, leadership and talent, equality, diversity and inclusion, employee relations, reward, workforce systems and analytics, and education and professional development. The CPO will be a trusted adviser to the Chair, Chief Executive and Board, and a credible, values-led partner to clinical, research and operational leaders at every level of the organisation.
We are seeking an exceptional executive leader with significant board or executive-level experience of successful people leadership in a large, complex organisation. Candidates will bring a demonstrable track record of shaping and delivering workforce strategy in environments of transformation and change, deep experience of building high-performing people functions, and the credibility to operate at the top table of one of the NHS’s most respected specialist trusts. Above all, we are looking for a leader who is strategic, intellectually curious and personally values-driven, with a track record of delivering excellence and impact, a genuine commitment to inclusion, and the resilience and judgement to lead through complexity.
This is a rare opportunity to shape the workforce agenda at one of the world’s leading cancer centres, at a moment of real consequence for the Trust and the patients it serves.
The MBS Group are acting as The Royal Marsden’s advisors on this appointment. Please find the Candidate Information Pack here. To apply please send a covering letter and CV to [email protected] by midnight on Monday 20 July.